Herriot Tabuteau
Overview
Herriot Tabuteau received an average of $3M in total compensation, including $444K in salary, at Axsome Therapeutics from 2014 to 2021.
2021Axsome TherapeuticsChief Executive Officer, President and Chairman of the Board
2020Axsome TherapeuticsChief Executive Officer, President and Chairman of the Board
2019Axsome TherapeuticsChief Executive Officer and Chairman of the Board
2018Axsome TherapeuticsChief Executive Officer and Chairman of the Board
2017Axsome TherapeuticsChief Executive Officer and Chairman of the Board
2016Axsome TherapeuticsChief Executive Officer and Chairman of the Board
2015Axsome TherapeuticsChief Executive Officer and Chairman of the Board
2014Axsome TherapeuticsChief Executive Officer and Chairman of the Board
Source: SEC filings on April 22, 2022, April 23, 2021, April 21, 2020, April 27, 2018, April 28, 2017, and April 27, 2016.
Related executives
We found six more executives who work or worked at Axsome Therapeutics.
Mark MA
Axsome Therapeutics
Chief Operating Officer
Nick Pizzie
Axsome Therapeutics
Chief Financial Officer
David Marek
Axsome Therapeutics
Former Chief Commercial Officer
John Golubieski
Axsome Therapeutics
Chief Financial Officer
Constance Ames
Axsome Therapeutics
Former Vice President, Finance and Treasurer
Randall Kaye
Axsome Therapeutics